Kitamura Hiroshi, Ikeda Kazuki, Honda Toyohiko, Ogino Tetsuro, Nakase Hiroshi, Chiba Tsutomu
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kawara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan.
Intern Med. 2006;45(19):1087-91. doi: 10.2169/internalmedicine.45.1760. Epub 2006 Nov 1.
Hepatoid adenocarcinoma (HAC) is a rare tumor that occurs mostly in the gastrointestinal tract. We encountered a 68-year-old man suffering from HAC with severe ascites. The serum and ascitic alpha-fetoprotein (AFP) levels were markedly high. Computed tomography (CT) revealed that multiple nodular lesions were disseminated only in the peritoneal cavity. Based on laparoscopic and histological findings, this tumor was diagnosed as diffuse HAC which was developed primarily in the peritoneum. Despite treatments with appropriate chemotherapy, he died six months after diagnosis. According to literature updates, this is the first documented case of diffuse HAC which developed in the peritoneum.
肝样腺癌(HAC)是一种罕见的肿瘤,主要发生在胃肠道。我们遇到一名68岁患有HAC并伴有严重腹水的男性。血清和腹水甲胎蛋白(AFP)水平显著升高。计算机断层扫描(CT)显示多个结节性病变仅散布于腹腔。根据腹腔镜检查和组织学检查结果,该肿瘤被诊断为主要在腹膜发生的弥漫性HAC。尽管接受了适当的化疗,他在诊断后六个月死亡。根据文献更新,这是首例有记录的腹膜发生的弥漫性HAC病例。